Ord Minnett
22 January 2021 – Ord Minnett (Ords), a leading Australian wealth management group, incorporating full-service stockbroking, financial planning, funds management and portfolio services, is pleased to announce the appointment of several key appointments to the Institutional Equities Sales & Research and Private Client Research teams.
Key Appointments
Ord Minnett welcomes the following key appointments:
· Michael Gerges as Senior Research Analyst (Healthcare) who joined the Sydney Institutional Research team on 11 January from Blue Ocean Equities where he covered the healthcare sector including pharmacy, pharmaceuticals, IVF clinics and diagnostic imaging among other sub-sectors in health. Michael was a pharmacist having operated a network of stores around the Hunter region.
Share:
SYDNEY, Dec. 15, 2020 /PRNewswire/ Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has completed a capital raising of $25,000,410.
Dr Alan Taylor, Executive Chairman of Clarity Pharmaceuticals, commented, It has been a pivotal year for Clarity with numerous critical milestones achieved in the development of our main products, advancement of our platform, as well as accelerated corporate and strategic activities despite facing an unprecedented global environment. The money raised will enable us to keep the momentum from 2020 going and provide financial resources to progress the following important initiatives: